Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1989; 82(Suppl 17): 57–62.
PMCID: PMC1291943

Future potential of malaria vaccines.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Cattani JA. Malaria vaccines: results of human trials and directions of current research. Exp Parasitol. 1989 Feb;68(2):242–247. [PubMed]
  • Miller LH. Current prospects and problems for a malaria vaccine. J Infect Dis. 1977 May;135(5):855–864. [PubMed]
  • Cohen S. Progress in malaria vaccine development. Br Med Bull. 1982 May;38(2):161–165. [PubMed]
  • Weber JL. Molecular biology of malaria parasites. Exp Parasitol. 1988 Aug;66(2):143–170. [PubMed]
  • Bruce-Chwatt LJ, Southgate BA, Draper CC. Malaria in the United Kingdom. Br Med J. 1974 Jun 29;2(5921):707–711. [PMC free article] [PubMed]
  • Callow LL. Vaccination against bovine babesiosis. Adv Exp Med Biol. 1977;93:121–149. [PubMed]
  • Clyde DF, Most H, McCarthy VC, Vanderberg JP. Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci. 1973 Sep;266(3):169–177. [PubMed]
  • Smith GL, Mackett M, Moss B. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature. 1983 Apr 7;302(5908):490–495. [PubMed]
  • Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG, Lerner RA, Rowlands DJ, Brown F. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature. 1982 Jul 1;298(5869):30–33. [PubMed]
  • Arnon R. Peptides as immunogens: prospects for synthetic vaccines. Curr Top Microbiol Immunol. 1986;130:1–12. [PubMed]
  • Collins WE, Anders RF, Pappaioanou M, Campbell GH, Brown GV, Kemp DJ, Coppel RL, Skinner JC, Andrysiak PM, Favaloro JM, et al. Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum. Nature. 1986 Sep 18;323(6085):259–262. [PubMed]
  • Collins WE, Pappaioanou M, Anders RF, Campbell GH, Brown GV, Kemp DJ, Broderson JR, Coppel RL, Skinner JC, Procell PM, et al. Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans). Am J Trop Med Hyg. 1988 Mar;38(2):268–282. [PubMed]
  • Cheung A, Leban J, Shaw AR, Merkli B, Stocker J, Chizzolini C, Sander C, Perrin LH. Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8328–8332. [PubMed]
  • Holder AA, Freeman RR, Nicholls SC. Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli. Parasite Immunol. 1988 Nov;10(6):607–617. [PubMed]
  • Patarroyo ME, Amador R, Clavijo P, Moreno A, Guzman F, Romero P, Tascon R, Franco A, Murillo LA, Ponton G, et al. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature. 1988 Mar 10;332(6160):158–161. [PubMed]
  • Sacks DL, Esser KM, Sher A. Immunization of mice against African trypanosomiasis using anti-idiotypic antibodies. J Exp Med. 1982 Apr 1;155(4):1108–1119. [PMC free article] [PubMed]
  • Grzych JM, Capron M, Lambert PH, Dissous C, Torres S, Capron A. An anti-idiotype vaccine against experimental schistosomiasis. Nature. 1985 Jul 4;316(6023):74–76. [PubMed]
  • Dreesman GR, Kennedy RC. Anti-idiotypic antibodies: implications of internal image-based vaccines for infectious diseases. J Infect Dis. 1985 May;151(5):761–765. [PubMed]
  • Potocnjak P, Zavala F, Nussenzweig R, Nussenzweig V. Inhibition of idiotype--anti-idiotype interaction for detection of a parasite antigen: a new immunoassay. Science. 1982 Mar 26;215(4540):1637–1639. [PubMed]
  • Hommel M. Malaria: immunity and prospects for vaccination. West J Med. 1981 Oct;135(4):285–299. [PMC free article] [PubMed]
  • de la Cruz VF, Maloy WL, Miller LH, Lal AA, Good MF, McCutchan TF. Lack of cross-reactivity between variant T cell determinants from malaria circumsporozoite protein. J Immunol. 1988 Oct 1;141(7):2456–2460. [PubMed]
  • Tanabe K, Mackay M, Goman M, Scaife JG. Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. J Mol Biol. 1987 May 20;195(2):273–287. [PubMed]
  • Saint RB, Coppel RL, Cowman AF, Brown GV, Shi PT, Barzaga N, Kemp DJ, Anders RF. Changes in repeat number, sequence, and reading frame in S-antigen genes of Plasmodium falciparum. Mol Cell Biol. 1987 Aug;7(8):2968–2973. [PMC free article] [PubMed]
  • Forsyth KP, Anders RF, Cattani JA, Alpers MP. Small area variation in prevalence of an S-antigen serotype of Plasmodium falciparum in villages of Madang, Papua New Guinea. Am J Trop Med Hyg. 1989 Apr;40(4):344–350. [PubMed]
  • Brown KN, Brown IN. Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi. Nature. 1965 Dec 25;208(5017):1286–1288. [PubMed]
  • McLean SA, Pearson CD, Phillips RS. Plasmodium chabaudi: antigenic variation during recrudescent parasitaemias in mice. Exp Parasitol. 1982 Dec;54(3):296–302. [PubMed]
  • Hommel M, David PH, Oligino LD. Surface alterations of erythrocytes in Plasmodium falciparum malaria. Antigenic variation, antigenic diversity, and the role of the spleen. J Exp Med. 1983 Apr 1;157(4):1137–1148. [PMC free article] [PubMed]
  • David PH, Hudson DE, Hadley TJ, Klotz FW, Miller LH. Immunization of monkeys with a 140 kilodalton merozoite surface protein of Plasmodium knowlesi malaria: appearance of alternate forms of this protein. J Immunol. 1985 Jun;134(6):4146–4152. [PubMed]
  • Spitalny GL, Verhave JP, Meuwissen JH, Nussenzweig RS. Plasmodium berghei: T cell dependence of sporozoite-induced immunity in rodents. Exp Parasitol. 1977 Jun;42(1):73–81. [PubMed]
  • Yoshida N, Nussenzweig RS, Potocnjak P, Nussenzweig V, Aikawa M. Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science. 1980 Jan 4;207(4426):71–73. [PubMed]
  • Mazier D, Miltgen F, Nudelman S, Nussler A, Renia L, Pied S, Goma J, Gentilini M. Pre-erythrocytic stages of plasmodia. Role of specific and nonspecific factors. Biol Cell. 1988;64(2):165–172. [PubMed]
  • Good MF, Berzofsky JA, Miller LH. The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development. Annu Rev Immunol. 1988;6:663–688. [PubMed]
  • Del Giudice G, Engers HD, Tougne C, Biro SS, Weiss N, Verdini AS, Pessi A, Degremont AA, Freyvogel TA, Lambert PH, et al. Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children. Am J Trop Med Hyg. 1987 Mar;36(2):203–212. [PubMed]
  • Sinigaglia F, Guttinger M, Kilgus J, Doran DM, Matile H, Etlinger H, Trzeciak A, Gillessen D, Pink JR. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature. 1988 Dec 22;336(6201):778–780. [PubMed]
  • Hommel M, Semoff S. Expression and function of erythrocyte-associated surface antigens in malaria. Biol Cell. 1988;64(2):183–203. [PubMed]
  • Jensen JB, Boland MT, Allan JS, Carlin JM, Vande Waa JA, Divo AA, Akood MA. Association between human serum-induced crisis forms in cultured Plasmodium falciparum and clinical immunity to malaria in Sudan. Infect Immun. 1983 Sep;41(3):1302–1311. [PMC free article] [PubMed]
  • MILLER MJ. Observations on the natural history of malaria in the semi-resistant West African. Trans R Soc Trop Med Hyg. 1958 Mar;52(2):152–168. [PubMed]
  • Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert PH. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med. 1989 Jun 15;320(24):1586–1591. [PubMed]
  • Halstead SB. Dengue haemorrhagic fever--a public health problem and a field for research. Bull World Health Organ. 1980;58(1):1–21. [PubMed]
  • Peiris JS, Premawansa S, Ranawaka MB, Udagama PV, Munasinghe YD, Nanayakkara MV, Gamage CP, Carter R, David PH, Mendis KN. Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria. Am J Trop Med Hyg. 1988 Jul;39(1):26–32. [PubMed]
  • Saul A. Kinetic constraints on the development of a malaria vaccine. Parasite Immunol. 1987 Jan;9(1):1–9. [PubMed]
  • Perlmann P. Immunogenicity assays for clinical trials of malaria vaccines. Parasitol Today. 1986 May;2(5):127–130. [PubMed]
  • Brown AW, Haworth J, Zahar AR. Malaria eradication and control from a global standpoint. J Med Entomol. 1976 May 29;13(1):1–25. [PubMed]
  • Poore P. Vaccination strategies in developing countries. Vaccine. 1988 Oct;6(5):393–398. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press